Quote:
Originally Posted by hamfisted
The most talked about shortfall of this LOA is forced deployments for 90 days.
And that is unfortunate. The most talked about shortfall of this LOA
should be the monumental
concessionary nature of this thing. STV is merely one of the many concessions in this document. It's understandably getting a lot of attention because it turns this into something that can affect more people than just those who bid it.
But STV does not affect those who would actually bid the FDA's. STV is the red herring in this whole thing. It will be the issue that gets the company these FDAs at such a low cost, they will be laughing at us for years to come! Watch this thing get voted down, the company throws a few more pennies at us and reduces the STV to say...oh, 45 days, and whammo, 95% vote yes for a slightly polished turd. Or worse yet, it gets voted IN and all of this goes as-is. Scary.